Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?

Type 2 diabetes is one of the major causes of mortality with rapidly increasing prevalence. Pharmacological treatment is the first recommended approach after failure in lifestyle changes. However, a significant number of patients shows—or develops along time and disease progression—drug resistance....

Descripción completa

Detalles Bibliográficos
Autores principales: Pollastro, Carla, Ziviello, Carmela, Costa, Valerio, Ciccodicola, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486250/
https://www.ncbi.nlm.nih.gov/pubmed/26161088
http://dx.doi.org/10.1155/2015/415149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486250/
https://www.ncbi.nlm.nih.gov/pubmed/26161088
http://dx.doi.org/10.1155/2015/415149

Ejemplares similares